Inventor · disambiguated record
David R. Witty
Also filed as: WITTY DAVID · WITTY DAVID R · WITTY DAVID RICHARD
27 granted patents·21 pending applications·177 citations·filing 1990–2022
96Inventor score
Files withCONVERGENCE PHARMACEUTICALS11GLAXO GROUP LTD11SMITHKLINE BEECHAM PLC5BIOGEN INC3BICYCLETX LTD2
Top patents by PatentIndex Score
48 records- 0197US11396530B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2020·Granted Jul 26, 2022·16 cites·22 claims
- 0296US10919937B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2019·Granted Feb 16, 2021·29 cites·25 claims
- 0392US7601837B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2008·Granted Oct 13, 2009·15 cites·3 claims
- 0490US7799774B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2009·Granted Sep 21, 2010·11 cites·15 claims
- 0589US7977337B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2010·Granted Jul 12, 2011·11 cites·10 claims
- 0688US8236947B2Quinoline derivatives and their use as 5-HT6 ligandsAHMED MAHMOOD·Filed 2011·Granted Aug 7, 2012·11 cites·18 claims
- 0785US9737536B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2016·Granted Aug 22, 2017·3 cites·13 claims
- 0884US9376445B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2013·Granted Jun 28, 2016·4 cites·11 claims
- 0983US10010551B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2017·Granted Jul 3, 2018·2 cites·10 claims
- 1083US9309254B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2013·Granted Apr 12, 2016·4 cites·24 claims
- 1180US7285557B2Pyrimidinones as melanin concentrating hormone receptor 1SMITHKLINE BEECHAM PLC·Filed 2002·Granted Oct 23, 2007·15 cites·25 claims
- 1279US10485801B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2018·Granted Nov 26, 2019·1 cites·14 claims
- 1378US7220777B2Lactam derivatives as antagonists for human 11cby receptorsSMITHKLINE BEECHAM PLC·Filed 2002·Granted May 22, 2007·16 cites·14 claims
- 1477US7439243B2Piperazinyl-quinoline derivatives useful for the treatment of CNS disordersGLAXO GROUP LTD·Filed 2004·Granted Oct 21, 2008·9 cites·12 claims
- 1572US2020289508A1Novel pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2019·Application pending·0 cites
- 1670US2022033408A1Process for preparing spiro derivativesBIOGEN INC·Filed 2021·Application pending·0 cites
- 1767US10421716B2Process for preparing alpha-carboxamide pyrrolidine derivativesCONVERGENCE PHARMACEUTICALS·Filed 2015·Granted Sep 24, 2019·1 cites·26 claims
- 1867US9376436B22-(pyridin-2yl)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulatorsCONVERGENCE PHARMACEUTICALS·Filed 2012·Granted Jun 28, 2016·1 cites·12 claims
- 1965US5013842ASynthesis of chiral pyrrolidine and piperidine glycosidase inhibitorsMONSANTO CO·Filed 1990·Granted May 7, 1991·20 cites·4 claims
- 2063US11149039B2Process for preparing spiro derivativesBIOGEN INC·Filed 2018·Granted Oct 19, 2021·0 cites·19 claims
- 2162US7514562B2Urea derivatives and their use as vanilloid receptor antagonists in the treatment of painGLAXO GROUP LTD·Filed 2004·Granted Apr 7, 2009·1 cites·14 claims
- 2261US9585886B2ASK1 inhibiting pyrrolopyrimidine derivativesCALCHAN LTD·Filed 2015·Granted Mar 7, 2017·1 cites·16 claims
- 2361US9045485B2ASK 1 inhibiting pyrrolopyrimidine derivativesWITTY DAVID R·Filed 2011·Granted Jun 2, 2015·1 cites·17 claims
- 2461US2024400608A1Synthesis of bicycle toxin conjugates, and intermediates thereofBRICYCLETX LTD·Filed 2022·Application pending·0 cites
- 2559US9303032B22-(pyridin-2YL)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulatorCONVERGENCE PHARMACEUTICALS·Filed 2012·Granted Apr 5, 2016·0 cites·7 claims
- 2659US2016184306A1Novel Pyrimidinyl-DiazoSpiro CompoundsCONVERGENCE PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 2758US2022169653A1Pyrrolopyrimidine and pyrrolopyridine derivativesGALAPAGOS NV·Filed 2021·Application pending·0 cites
- 2852US11136325B2Pyrrolopyrimidine and pyrrolopyridine derivativesGALAPAGOS NV·Filed 2018·Granted Oct 5, 2021·0 cites·14 claims
- 2949US7439244B2Quinoline compounds and pharmeceutical compositions containing themGLAXO GROUP LTD·Filed 2004·Granted Oct 21, 2008·0 cites·13 claims
- 3049US6048852Aβ-thiopropionyl-aminoacid derivatives and their use as β-lactamase inhibitorsSMITHKLINE BEECHAM PLC·Filed 1997·Granted Apr 11, 2000·4 cites·23 claims
- 3149US2016185758A12-(Pyridin-2-yl)-1, 7-Diaza-Spiro [4.4] Nonane-6-One Compound as Voltage-Gated Sodium Channel ModulatorCONVERGENCE PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 3249US2006287321A1Novel Lactam DerivativesSMITHKLINE BEECHAM PLC·Filed 2006·Application pending·0 cites
- 3348US2008275040A18-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns DisordersGLAXO GROUP LTD·Filed 2004·Application pending·0 cites
- 3448US2023181749A1Bicyclic peptide ligands specific for nectin-4 and uses thereofBICYCLE TX LTD·Filed 2021·Application pending·0 cites
- 3547US7528151B2Heterocyclic urea derivatives for the treatment of painGLAXO GROUP LTD·Filed 2004·Granted May 5, 2009·0 cites·6 claims
- 3645US2004063686A1Carboxamide compounds and their use as antagonists of a human 11cby receptorFiled 2001·Application pending·0 cites
- 3744US2009012056A1Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 ReceptorGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 3843US2005124626A1Novel compoundsFiled 2003·Application pending·0 cites
- 3942US2007249603A13-Arylsulfonyl-Quinolines as 5-Ht6 Receptor Antagonists for the Treatment of Cns DisordersJOHNSON CHRISTOPHER N·Filed 2005·Application pending·0 cites
- 4042US2004242589A13-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disordersFiled 2002·Application pending·0 cites
- 4142US2005176759A17-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disordersFiled 2002·Application pending·0 cites
- 4242US2017210748A1Ask 1 inhibiting pyrrolopyrimidine derivativesCALCHAN LTD·Filed 2017·Application pending·0 cites
- 4341US2020255438A1Novel saltsBIOGEN INC·Filed 2018·Application pending·0 cites
- 4441US2005222124A1Benzenesulfonamide derivatives as antipsychotic agentsBROMIDGE STEVEN M·Filed 2003·Application pending·0 cites
- 4541US2005090485A17-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disordersFiled 2003·Application pending·0 cites
- 4641US2008318933A15-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns DisordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 4740US2007191345A13-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 4833US6156774ABeta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitorsSMITHKLINE BEECHAM PLC·Filed 1997·Granted Dec 5, 2000·1 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when David R. Witty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →